Fibroadenoma interventions: Difference between revisions
(Created page with "__NOTOC__ {{Xyz}} {{CMG}}; {{AE}} {{S.G.}} ==Overview== There are no recommended therapeutic interventions for the management of [disease name]. OR [Name of intervention] i...") |
|||
| Line 24: | Line 24: | ||
==Indications== | ==Indications== | ||
===Observation=== | |||
* Most fibroadenomas are managed conservatively with yearly breast examination and ultrasound if necessary. This is related to the fact that about 10 to 40% of fibroadenomas regress spontaneously. | |||
==References== | ==References== | ||
Revision as of 19:53, 31 January 2019
|
Xyz Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Fibroadenoma interventions On the Web |
|
American Roentgen Ray Society Images of Fibroadenoma interventions |
|
Risk calculators and risk factors for Fibroadenoma interventions |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sogand Goudarzi, MD [2]
Overview
There are no recommended therapeutic interventions for the management of [disease name].
OR
[Name of intervention] is not the first-line treatment option for patients with [disease name]. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and [indication 3]
OR
The mainstay of treatment for [disease name] is medical therapy/surgery. [Name of intervention] is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
OR
The feasibility of [name of intervention] depends on the stage of [disease or malignancy] at the time of diagnosis.
OR
[Name of intervention] is the mainstay of treatment for [disease or malignancy].
Indications
Observation
- Most fibroadenomas are managed conservatively with yearly breast examination and ultrasound if necessary. This is related to the fact that about 10 to 40% of fibroadenomas regress spontaneously.